Dudediligence.

Climb Bio, Inc

CLYMNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,736,968

4 notices · 280,902 sh

Oct 2025 to Oct 2026

Reported ·

$878,963

4 sales · 3 buys · $779,626 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 4 reported sales carry the 10b5-1 box. Together they are 0.26% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: STEPHEN THOMAS, Form 1442026-06-29: AOIFE BRENNAN, Form 1442026-02-25: STEPHEN THOMAS, Form 1442026-02-12: STEPHEN THOMAS, Form 1442025-12-11: RA Capital Healthcare Fund LP, bought2026-01-05: RA Capital Healthcare Fund LP, bought2026-02-12: Thomas Stephen Basil, sold2026-02-25: Thomas Stephen Basil, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-15STEPHEN THOMAS, Director$1,456,000
100,000 shplan 2026-06-16Form 4s on file end Jun 23144 ↗
2026-06-29AOIFE BRENNAN, President and CEO$406,968
30,902 sh10b5-1 plan144 ↗
Form 4, 2026-06-30: sold 30,902 at $13.17 Form 4 ↗
2026-02-25STEPHEN THOMAS, Director$318,000
50,000 shplan 2025-10-14144 ↗
Form 4, 2026-02-27: sold 50,000 at $7.00 Form 4 ↗
2026-02-12STEPHEN THOMAS, Director$556,000
100,000 shplan 2025-10-14144 ↗
Form 4, 2026-02-17: sold 100,000 at $5.29 Form 4 ↗